Abstract 072: Risk Factors for Developing Ischemic Strokes While Taking Non‐Vitamin K Antagonist Oral Anticoagulants

Abstract 072: Risk Factors for Developing Ischemic Strokes While Taking Non‐Vitamin K Antagonist Oral Anticoagulants

Introduction Over the past decade, non‐vitamin K antagonist oral anticoagulants (NOACs) have replaced warfarin as the initial strategy for stroke prevention in non‐valvular atrial fibrillation. However, ischemic strokes occurring in patients taking NOACs are becoming increasingly more frequent. In t...

Descripció completa

Dades bibliogràfiques
Autors principals:	Alvin S. Das, Elif Gokcal, Avia Abramovitz Fouks, Mitchell Horn, Robert Regenhardt, Anand Viswanathan, Aneesh Singhal, Lee Schwamm, Steven Greenberg, Edip Gurol
Format:	Article
Idioma:	English
Publicat:	Wiley 2023-11-01
Col·lecció:	Stroke: Vascular and Interventional Neurology
Accés en línia:	https://www.ahajournals.org/doi/10.1161/SVIN.03.suppl_2.072

Ítems similars

Left atrial appendage closure in patients with atrial fibrillation and acute ischaemic stroke despite anticoagulation
per: Shadi Yaghi, et al.

Left atrial appendage closure for patients with atrial fibrillation at high intracranial haemorrhagic risk
per: Shadi Yaghi, et al.

Improving detection of cerebral small vessel disease aetiology in patients with isolated lobar intracerebral haemorrhage
per: Jonathan Rosand, et al.

Peak width of skeletonized mean diffusivity and cognitive performance in cerebral amyloid angiopathy
per: Mitchell J. Horn, et al.
Publicat: (2023-04-01)

Minocycline in Severe Cerebral Amyloid Angiopathy: A Single‐Center Cohort Study
per: Francesco Bax, et al.
Publicat: (2024-02-01)

072 WORSENING RENAL FUNCTION IN HEART FAILURE PATIENTS
per: M.H. Tan, et al.
Publicat: (2017-08-01)

P.072 THE DIFFERENTIATION IN THE CONTRIBUTION OF VASCULAR AND CEREBRAL SEGMENTS TO BRS
per: N.P. Saeed*, et al.
Publicat: (2007-06-01)

P072: Impact of Ageing on the Survivorship Experiences of Patients with Hodgkin Lymphoma
per: Cherie Bates, et al.
Publicat: (2022-10-01)

Effects of L-valine in layer diets containing 0.72% isoleucine.
per: Usman Liaqat, et al.
Publicat: (2022-01-01)

Effects of L-valine in layer diets containing 0.72% isoleucine
per: Usman Liaqat, et al.
Publicat: (2022-01-01)

CX-072 (pacmilimab), a Probody® PD-L1 inhibitor, in advanced or recurrent solid tumors (PROCLAIM-CX-072): an open-label dose-finding and first-in-human study
per: Hendrik-Tobias Arkenau, et al.
Publicat: (2021-07-01)

CX-072 (pacmilimab), a Probody PD-L1 inhibitor, in combination with ipilimumab in patients with advanced solid tumors (PROCLAIM-CX-072): a first-in-human, dose-finding study
per: Omid Hamid, et al.
Publicat: (2021-07-01)

Cerebral Amyloid Angiopathy
per: Mahmut Edip Gürol
Publicat: (2009-03-01)

Anticoagulants in clinical practice. The place of vitamin K antagonists in combination with new oral anticoagulants
per: T. V. Vavilova
Publicat: (2015-12-01)

Anticoagulation in sub-saharan africa with the advent of non-vitamin K antagonist oral anticoagulants
per: Raphael Chinedu Anakwue
Publicat: (2020-01-01)

Non-Anticoagulant Heparins Are Hepcidin Antagonists for the Treatment of Anemia
per: Maura Poli, et al.
Publicat: (2017-04-01)

P072: Assessing the characteristics associated with carriers of the CHEK2 S428F variant
per: Calan Szmyd, et al.
Publicat: (2024-01-01)

PG 1605+072 in Wet XCov22: Support for the Multi Site Spectroscopic Telescope
per: Schuh S. L., et al.
Publicat: (2003-03-01)

POS-072 PRACTICAL EXPERIENCE WITH THE IMPLEMENTATION OF NGAL FOR AKI DIAGNOSIS IN A CLINICAL SETTING
per: J.M. COTE, et al.
Publicat: (2021-04-01)

Repeatability of the Seasonal Variations of Ozone near the Mesopause from Observations of the 11.072-GHz Line
per: Rogers, Alan E. E., et al.
Publicat: (2013)

Seasonal and Diurnal Variations of Ozone near the Mesopause from Observations of the 11.072-GHz Line
per: Pratap, P., et al.
Publicat: (2010)

072. Subhepatic Appendicitis in A 23 Year Old Woman: A Rare Case Report
per: Apidha Kartinasari, et al.
Publicat: (2024-11-01)

Psychometric and structural properties of the Karolinska Exhaustion Disorder Scale: a 1,072-patient study
per: Elin Lindsäter, et al.
Publicat: (2023-09-01)

072 Impact of telehealth on multiple sclerosis (MS) outpatient clinics during the COVID-19 pandemic
per: Trevor Kilpatrick, et al.
Publicat: (2021-08-01)

Updates on Anticoagulation and Laboratory Tools for Therapy Monitoring of Heparin, Vitamin K Antagonists and Direct Oral Anticoagulants
per: Osamu Kumano, et al.
Publicat: (2021-03-01)

Safety and effectiveness of anticoagulation with non-vitamin K antagonist oral anticoagulants and warfarin in patients on tuberculosis treatment
per: Hyun-Jung Lee, et al.
Publicat: (2023-02-01)

Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants
per: Susin Park, et al.
Publicat: (2022-01-01)

An Update on the Reversal of Non-Vitamin K Antagonist Oral Anticoagulants
per: Mark Terence P. Mujer, et al.
Publicat: (2020-01-01)

Non-vitamin K antagonist oral anticoagulants for heart diseases
per: T B Kondratieva, et al.
Publicat: (2017-09-01)

A prospective comparative study to assess the risk of postoperative bleeding after dental surgery while on medication with direct oral anticoagulants, antiplatelet agents, or vitamin K antagonists
per: Mayte Buchbender, et al.
Publicat: (2021-10-01)

Asymptomatic Cerebral Small Vessel Disease: Insights from Population-Based Studies
per: Alvin S. Das, et al.
Publicat: (2019-05-01)

Advances in Stroke Prevention in 2018
per: M. Edip Gurol, et al.
Publicat: (2018-05-01)

P-072: COST COMPARISON OF TRANSFUSION CHOICES IN OMAN FOR PATIENTS SUFFERING FROM SICKLE CELL DISEASE.
per: AL KINDI S., et al.
Publicat: (2022-08-01)

Overexpression of cotton GhNAC072 gene enhances drought and salt stress tolerance in transgenic Arabidopsis
per: Teame Gereziher Mehari, et al.
Publicat: (2022-09-01)

Vitamin K Antagonists, Non–Vitamin K Antagonist Oral Anticoagulants, and Vascular Calcification in Patients with Atrial Fibrillation
per: Frederique E. C. M. Peeters, et al.
Publicat: (2018-10-01)

Non-Vitamin K Antagonist Oral Anticoagulants in Patients with β-Thalassemia
per: Michele Malagù, et al.
Publicat: (2023-03-01)

Stability of vitamin K antagonist anticoagulation after COVID‐19 diagnosis
per: Eleonora Camilleri, et al.
Publicat: (2021-10-01)

Non-vitamin K antagonist oral anticoagulants for COVID-19 thrombosis
per: Adel Khalifa Sultan Hamad
Publicat: (2022-01-01)

Tooth extraction in patients taking nonvitamin K antagonist oral anticoagulants
per: Yoshinari Morimoto, et al.
Publicat: (2016-03-01)

Nonvitamin K antagonist oral anticoagulants (NOACs): the tide continues to come in
per: Blann A
Publicat: (2015-08-01)